# A Study of CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies

> **NCT05028478** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Curon Biopharmaceutical (Australia) Co Pty Ltd** · enrollment: 164 (estimated)

## Conditions studied

- Locally Advanced Solid Tumor
- Metastatic Solid Tumor
- Hematologic Malignancies

## Interventions

- **DRUG:** CN202

## Key facts

- **NCT ID:** NCT05028478
- **Lead sponsor:** Curon Biopharmaceutical (Australia) Co Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-22
- **Primary completion:** 2023-02-10
- **Final completion:** 2023-10-06
- **Target enrollment:** 164 (ESTIMATED)
- **Last updated:** 2021-08-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05028478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05028478, "A Study of CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05028478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*